a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with ADMA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then ADMA could also see price increases.
Ticker / NAME | Correlation To IMTX | 1D Price Change % | ||
---|---|---|---|---|
IMTX | 100% | +1.06% | ||
ADMA - IMTX | 37% Loosely correlated | -1.42% | ||
TECH - IMTX | 35% Loosely correlated | +2.04% | ||
MRUS - IMTX | 33% Poorly correlated | -1.36% | ||
PTGX - IMTX | 32% Poorly correlated | -1.16% | ||
KRRO - IMTX | 30% Poorly correlated | -15.55% | ||
More |
Ticker / NAME | Correlation To IMTX | 1D Price Change % |
---|---|---|
IMTX | 100% | +1.06% |
germany theme (2 stocks) | 90% Closely correlated | -1.69% |
biopharmaceutical theme (10 stocks) | 42% Loosely correlated | -2.76% |
therapeutic theme (4 stocks) | 33% Loosely correlated | -5.34% |
cancer theme (82 stocks) | 33% Poorly correlated | -2.38% |
treatment theme (56 stocks) | 32% Poorly correlated | -1.12% |